Focal Vibration Therapy in Post-stroke Shoulder Pain
Italy60 participantsStarted 2026-04-01
Plain-language summary
Hemiplegic Shoulder Pain (HSP) is a common and disabling complication after stroke, negatively affecting upper limb function, participation in rehabilitation, and quality of life. Despite the widespread use of conservative and physical therapies, evidence supporting the efficacy of specific non-invasive neuromodulation techniques remains limited.
Focal Vibration Therapy (FVT) is a non-invasive physical modality that delivers localized mechanical vibration to targeted muscles or tendons and may modulate pain, muscle tone, and proprioception through frequency-dependent mechanisms.
This randomized controlled trial aims to evaluate the efficacy of a multimodal FVT protocol, in addition to standard rehabilitation, compared with a sham intervention plus standard rehabilitation, in reducing pain in patients with chronic post-stroke Hemiplegic Shoulder Pain.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years
* Ischemic or hemorrhagic stroke confirmed by CT or MRI
* Chronic post-stroke phase (≥ 6 months from event)
* Presence of hemiplegic shoulder pain (NRS ≥ 4)
* Preserved cognitive function sufficient to provide informed consent
Exclusion Criteria:
* Severe cognitive impairment or language deficits (e.g., severe aphasia) that prevent understanding of study procedures or reliable reporting of pain (e.g., inability to complete NRS or questionnaires).
* Severe neglect, apraxia, or disorders of consciousness that interfere with participation in rehabilitation or outcome assessments.
* Pre-existing shoulder pathology of the affected side unrelated to stroke (e.g., full-thickness rotator cuff tear, advanced glenohumeral osteoarthritis, inflammatory arthritis, prior shoulder surgery).
* Fixed shoulder contractures or severe joint deformities limiting passive range of motion and preventing standardized assessment.
* Botulinum toxin injections to shoulder upper limb muscles within the last 3-4 months prior to enrollment .
* Current treatment with other experimental or non-conventional physical therapies for shoulder pain during the study period.
What they're measuring
1
Change in Pain Intensity Assessed by Numerical Rating Scale (NRS)
Timeframe: From baseline (Day 0) to the Day 15 (end of treatment)